TNF and myeloid sarcoma: Altogether these data clearly indicate that during MS, TNF released by immune cells might be sufficient to induce a diffuse glutamatergic synaptopathy [31] and the long-lasting effects of such phenomenon can be detrimental for brain function and integrity.